European Journal of Cancer
Volume 46, Issue 5 , Pages 863-868, March 2010

Future treatment of soft tissue sarcomas will be driven by histological subtype and molecular abberations

  • Jaap Verweij

      Affiliations

    • Dept. of Medical Oncology, Erasmus University Medical Center, Rotterdam, The Netherlands
    • Corresponding Author InformationCorresponding author: Address: Dept. of Medical Oncology, Erasmus University Medical Center, ’s-Gravendijkwal 230, 3015 CE Rotterdam, The Netherlands. Tel.: +31 10 7034447; fax: +31 10 7034627.
    • ,
  • Laurence H. Baker

      Affiliations

    • Departments of Internal Medicine and Pharmacology, University of Michigan, Ann Arbor, USA

Received 29 December 2009; accepted 14 January 2010. published online 08 February 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0959-8049(10)00035-3

doi:10.1016/j.ejca.2010.01.016

European Journal of Cancer
Volume 46, Issue 5 , Pages 863-868, March 2010

Article Tools